But it doesn't go with the décor: domesticating a telemedicine diabetes intervention in the home

Type 2 Diabetes (T2D) is a chronic disease that requires day-to-day management. Telemedicine is one way of providing support to patients, to manage and receive care from home. Medical researchers use clinical trials to evaluate telemedicine technologies by comparing medical improvements of the patients. However, the patients' interactions and experiences with the technology are important because unpleasant experiences may result in non-adherence to a medical program. HCI experts have contributed in user-centred evaluations for decades. This research complements a telemedicine clinical trial with human-centred evaluation to understand patients during the post- rollout phase. Findings present patients' placement of telemedicine device in their homes, patients' feelings of using the device and their family involvement, and our experiences of conducting a HCI research with medical researchers in a clinical trial. We conclude that though the telemedicine device is seen as life-saving, patients treat it just as a regular device. We conclude that telemedicine evaluations such as clinical trials can benefit from evaluation methods in HCI